Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate in Solid Tumors with Bone Metastases
NCT00003884Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 1998
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in bone metastases, sponsored by Novartis. Started Aug 1998; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00003884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003884.